ACS nano · 2025
A Nature-Inspired Steroid-like Electron Acceptor to Polarity-Dependent Probe for Visualizing Lipid Evolution in Alzheimer's Disease.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wu Lulu, Wang Wen-Jin, Lin Yuting, Xu Xuan, Zhong Weiren, Wang Jifu, Zhang Jianyu, Zhao Zheng, Kühn Fritz E, Xu Xu, Xu Yun, Tang Ben Zhong, Cai Xu-Min
Аннотация
Current petrochemical-based electron acceptors in advanced optical materials face problems such as structural diversity, renewability, and biocompatibility. Natural product-derived fluorescent materials with donor-acceptor structures, stimuli-responsive photophysical properties, and superior biocompatibility are crucial for biomedical applications like visualizing the lipid evolution in Alzheimer's disease (AD). In this work, a nature-inspired electron acceptor (DABT) analogous to steroids has been constructed based on the tricyclic diterpene skeleton of natural rosin. Through substitution with variable electron donors, the dimethyl amino-substituted compound, DABT-DMA, can be applied as a polarity-dependent biosensor with dual-stimuli responsiveness of distinct fluorescence wavelength and lifetime. The natural skeleton's advantageous biocompatibility and targeting capability enable lipid droplet-targeted imaging. Further investigations prove that the single biobased sensor can combine the bilateral advantages of two commercial probes, confirming that Aβ protein-induced lipid droplet dysfunction causes cholesterol analogue accumulation, worsening AD pathology. This work not only proposes a steroid-like natural electron acceptor with both biocompatibility and targeting capability but also offers insights into AD-related pathophysiological mechanisms.